Skip to main
University-wide Navigation

Research Advancing Kentucky: Restoring movement to those with spinal cord injuries

With NIH support, John Gensel focuses on developing therapies and treatments to improve outcomes after spinal cord injury.

UK researchers uncover hidden barrier to spinal cord injury recovery

Dr. Andrew Stewart is investigating why treatments that could help repair and regenerate the damaged spinal cord stop working shortly after the injury has occurred.

Physiology Scholars Program welcomes new cohort focused on biomedical research

Scholars are selected based on their academic achievements and a statement of interest in research. Four students were selected as 2024-25 Physiology Scholars.

‘I am a UK Innovator’: College of Arts and Sciences’ Samuel Awuah

Samuel Awuah, associate chemistry professor at UK, is developing gold-based compounds to be used in the treatment of diseases such as ulcerative colitis, traumatic brain injury and various forms of cancer.

College of Pharmacy hosting symposium on therapeutic manipulation of immune function

The College of Pharmacy  will host its 11th annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8 a.m.–5 p.m. April 12, at the Lee T. Todd, Jr. Building.

African American Research Training Scholars Present Neuroscience Research at 1st Symposium

The University of Kentucky Spinal Cord and Brain Injury Research Center (SCoBIRC) hosted a symposium last week featuring its first class of African American Research Training Scholars (AARTS).

Research Looks at Impact of Patient Sex on Treatment Strategies for Spinal Cord Injuries

Ultimately the study found that females who express the e4 allele of APOE have a negative response to intermittent hypoxia, indicating that treatment strategies may not be equally effective or beneficial for all individuals.

UK Receives $3.2 Million for Traumatic Brain Injury Research

The National Institutes of Health award will fund ongoing research led by UK Neuroscience and Spinal Cord and Brain Injury Research Center (SCoBIRC) Professor Patrick Sullivan, Ph.D., who has studied the effects of the experimental drug MP201 on TBI.

Chemistry Researcher Develops Innovative Testing, Potential Remedies for Head Trauma, Alzheimer's

"I really just developed a love for the campus." Mark Lovell credits a history of collaboration at UK for driving his research for the past 30 years.

Head Injuries and the Path from Pilot Study to Major Grant

A team of UK researchers have homed in on a protein, called RIT1, that may act as a master switch in the brain. A new five-year, $2.5 million grant from the National Institutes of Health will help them explore RIT1 as a possible target for treatments to counteract brain injury.

Filter News